Loading...

TLPH TALPHERA INC Earnings Reports 8-K Filing

TLPH

TLPH

TALPHERA INC

(TLPH)

2023 8-K

Financial Results Report

Annual Meeting Results

Compliance Regained

Board Appointment

Securities Sale Agreement

Financial Results Update

Failure to Meet Listing Sta...

Financial Statements

Securities Sale

Financial Results

Nasdaq Compliance Notice

Financial Results

Agreement Amendment

Management Change

Departure of Directors and ...

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Departure of Directors and ...

Private Placement

Agreement with XOMA for Pur...

Financial Results Announcement

Annual Meeting of Stockholders

Change in Registrant's Cert...

FDA Declines Emergency Use ...

Earnings Reports

Equity Offerings

Compliance with Nasdaq Mini...

Financial Results Announcement

Sale of DSUVIA and Loan Rep...

Financial Results and Resta...

Asset Purchase Agreement

External Links:

ACELRX PHARMACEUTICALS INC announced its financial results for the three and twelve months ended December 31, 2022 and identified an error in the earnings per share calculations in the interim financial statements for the three and six months ended June 30, 2022 and nine months ended September 30, 2022.

AI Assistant

TALPHERA INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.